ClassID:

21647

A61K2300/00 - page 11 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#3001
20180021405
2018-01-25

NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE

#3002
20180021401
2018-01-25

Compositions and methods for treatment of intracellular damage and bacterial infection

#3003
20180021391
2018-01-25

BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS

#3004
20180021388
2018-01-25

Avian follistatin product

#3005
20180021372
2018-01-25

TREATMENT METHODS FOR DEHYDRATION USING LIPOSOMAL REHYDRATION SALT FORMULATION

#3006
20180021366
2018-01-25

COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS

#3007
20180021365
2018-01-25

ENHANCED CANCER TREATMENT AND MONITORING USING RECOMBINANT VECTORS

#3008
20180021359
2018-01-25

COMBINATION COMPRISING AN OMEGA-3 FATTY ACID COMPOSITION AND AN SGLT2 INHIBITOR

#3009
20180021355
2018-01-25

Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease

#3010
20180021354
2018-01-25

Adjunctive Therapy With 25-Hydroxyvitamin D and Articles Therefor

#3011
20180021353
2018-01-25

Nutritional intervention for improving muscular function and strength

#3012
20180021349
2018-01-25

EMULSION FORMULATIONS

#3013
20180021345
2018-01-25

Autotaxin inhibitors

#3014
20180021344
2018-01-25

Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome

#3015
20180021340
2018-01-25

Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue

#3016
20180021337
2018-01-25

Salt of a pyrimido[6,1-A]isoquinolin-4-one compound

#3017
20180021327
2018-01-25

TREATMENT OF CORNEAL NEOVASCULARIZATION

#3018
20180021312
2018-01-25

Benzoisoxazole-substituted compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

#3019
20180021309
2018-01-25

SIGMA LIGANDS FOR POTENTIATING THE ANALGESIC EFFECT OF OPIOIDS AND OPIATES IN POST-OPERATIVE PAIN AND ATTENUATING THE DEPENDENCY THEREOF

#3020
20180021307
2018-01-25

Combination Treatment

#3021
20180021302
2018-01-25

PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#3022
20180021288
2018-01-25

Neuroprotection in Demyelinating Diseases

#3023
20180021272
2018-01-25

Formulations for oral administration of active agents

#3024
20180021254
2018-01-25

Compositions containing alpha-2-adrenergic agonist components

#3025
20180021227
2018-01-25

COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE

#3026
20180016263
2018-01-18

Inhibitors of the renal outer medullary potassium channel

#3027
20180016239
2018-01-18

Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof

#3028
20180016229
2018-01-18

USE OF ISOTHIOCYANATE FUNCTIONAL SURFACTANTS AS NRF2 INDUCERS TO TREAT EPIDERMOLYSIS BULLOSA SIMPLEX AND RELATED DISEASES

#3029
20180015112
2018-01-18

Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome

#3030
20180015111
2018-01-18

METHODS FOR ON DEMAND PRE-EXPOSURE PROPHYLACTIC TREATMENT OF HIV INFECTION

#3031
20180015067
2018-01-18

Combination therapies

#3032
20180015060
2018-01-18

Healing topical composition

#3033
20180015057
2018-01-18

ERR ALPHA AND ERR GAMMA ARE ESSENTIAL COORDINATORS OF CARDIAC METABOLISM AND FUNCTION

#3034
20180015052
2018-01-18

Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity

#3035
20180015013
2018-01-18

SYSTEM AND METHOD OF COMPLEMENTARY DAY/NIGHT CHILDREN'S SKIN CREAM COMPOSITIONS

#3036
20180009801
2018-01-11

Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors

#3037
20180008626
2018-01-11

Combination of hyaluronic acid and macrogol and pharmaceutical compositions containing it

#3038
20180008623
2018-01-11

Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection

#3039
20180008605
2018-01-11

Pteridine dione monocarboxylate transporter inhibitors

#3040
20180008586
2018-01-11

Gel local anesthetic agent and gel local anesthetic preparation using same

#3041
20180008579
2018-01-11

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHRONIC MYELOID LEUKEMIA AND METHOD USING THE SAME

#3042
20180008537
2018-01-11

Composition and method for treating congenital cytomegalovirus induced hearing loss

#3043
20180002311
2018-01-04

Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts

#3044
20180002283
2018-01-04

Diindole compounds useful in treatment of nervous system disorders

#3045
20180000892
2018-01-04

Methods and pharmaceutical compositions for the treatment of ischemic conditions

#3046
20180000845
2018-01-04

Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them

#3047
20180000824
2018-01-04

Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor

#3048
20180000811
2018-01-04

STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBACTERIAL AGENT

#3049
20180000803
2018-01-04

(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations

#3050
20180000775
2018-01-04

TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASES

#3051
20180000107
2018-01-04

Herbal Tea Compositions for Babies

#3052
20170369501
2017-12-28

Kv1.3 inhibitors and their medical applications

#3053
20170368182
2017-12-28

Pharmaceutical Semi-Solid Gels with Entrapped Calcium Phosphate Nanoparticles

#3054
20170368176
2017-12-28

NON-TOXIC TOPICAL ANESTHETIC OPHTHALMIC COMPOSITIONS

#3055
20170368111
2017-12-28

Reduction of milk glycans and their degradation products in the neonate gut

#3056
20170368075
2017-12-28

COMPOSITION

#3057
20170368066
2017-12-28

Solid antiviral dosage forms

#3058
20170368053
2017-12-28

TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD

#3059
20170368052
2017-12-28

CRYSTAL FORMS OF APOMORPHINE AND USES THEREOF

#3060
20170368035
2017-12-28

5,5-bicyclic oxazole orexin receptor antagonists

#3061
20170368032
2017-12-28

Imidazole-based antimicrobial agents

#3062
20170368031
2017-12-28

SOLID DISPERSION FORMULATIONS OF ANTIVIRAL COMPOUNDS

#3063
20170367977
2017-12-28

AQUEOUS COMPOSITION

#3064
20170367391
2017-12-28

Bars and Shakes utilizing proprietary blend of herbs for enhanced human lactation and breastfeeding.

#3065
20170362664
2017-12-21

Treatment of angiogenesis disorders

#3066
20170361126
2017-12-21

Compositions and Methods for Inducing Nanoparticle Mediated Microvascular Embolization of Tumors

#3067
20170360923
2017-12-21

Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants

#3068
20170360890
2017-12-21

Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen

#3069
20170360832
2017-12-21

Hypochlorous acid formulations and methods for treating skin conditions

#3070
20170360807
2017-12-21

Subcutaneously administered anti-IL-6 receptor antibody for treatment of juvenile idiopathic arthritis

#3071
20170360804
2017-12-21

C-19 steroids for inhibiting neovascularization

#3072
20170360792
2017-12-21

Organic compounds

#3073
20170360766
2017-12-21

3-(PIPERIDIN-4-YL)-ISOXAZOL-3(OH)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS

#3074
20170360760
2017-12-21

Inhibitors of bromodomains

#3075
20170360756
2017-12-21

Substituted heterocycles as bromodomain inhibitors

#3076
20170360753
2017-12-21

Organic compounds

#3077
20170360746
2017-12-21

Polymorph of granaticin B

#3078
20170360723
2017-12-21

USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME

#3079
20170360072
2017-12-21

Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids

#3080
20170356058
2017-12-14

Compositions and methods for detection of hepatitis C virus genotype 3

#3081
20170355683
2017-12-14

Quinazoline heterocyclic compound as EGFR kinase inhibitor and preparation and application thereof

#3082
20170354703
2017-12-14

Method for treating gout and gout-induced arthritis using composition containing mixed extract of and

#3083
20170354664
2017-12-14

Prodrugs of 17.BETA.-HSD1-inhibitors

#3084
20170354640
2017-12-14

Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome

#3085
20170349648
2017-12-07

Compositions and methods for treating and preventing infections

#3086
20170348368
2017-12-07

Medicinal composition of extract of seed of emblica officinalis and method of preparing the same

#3087
20170348329
2017-12-07

Combination Drug Therapy

#3088
20170348317
2017-12-07

Treatment of solid tumours

#3089
20170348301
2017-12-07

ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR

#3090
20170347652
2017-12-07

Enhancement of antibiotic efficacy

#3091
20170344714
2017-11-30

Ophthalmic drug delivery

#3092
20170342049
2017-11-30

1,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof

#3093
20170340745
2017-11-30

Nucleic acid complexes

#3094
20170340698
2017-11-30

CYCLIC PEPTIDE SPECIFICALLY BINDING TO APOPTOTIC CELLS AND USE THEREOF

#3095
20170340674
2017-11-30

Prevention of progressive heart failure

#3096
20170340663
2017-11-30

MINERAL COMPLEX FORMULATIONS FOR ORAL ADMINISTRATION AND METHODS FOR THEIR USE

#3097
20170340658
2017-11-30

COMBINED USE OF A CHEMOTHERAPEUTIC AGENT AND A CYCLIC DINUCLEOTIDE FOR CANCER TREATMENT

#3098
20170340631
2017-11-30

BTK inhibitors

#3099
20170334993
2017-11-23

Treatment of pediatric BCP-ALL patients with an anti-KIR antibody

#3100
20170334887
2017-11-23

Imidazole-based antimicrobial agents

#3101
20170334838
2017-11-23

Process for the preparation of raltegravir

#3102
20170333515
2017-11-23

COMPOSITIONS AND METHODS FOR ENHANCING THE METABOLIC ACTIVITY OR STABILITY OF CURCUMIN

#3103
20170333497
2017-11-23

Probiotic pathogen inhibition composition and method

#3104
20170333435
2017-11-23

SUBSTITUTED IMIDAZO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

#3105
20170333416
2017-11-23

Methods and devices for the treatment of ocular diseases in human subjects

#3106
20170333408
2017-11-23

Apilimod for use in the treatment of renal cancer

#3107
20170333370
2017-11-23

Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient

#3108
20170327590
2017-11-16

Methods of treating skin cancer by administering a PD-1 inhibitor

#3109
20170326243
2017-11-16

Methods and systems for treating or preventing cancer

#3110
20170326205
2017-11-16

Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation

#3111
20170326196
2017-11-16

Mouth freshener

#3112
20170326148
2017-11-16

Prevention or treatment of uratic or gouty diseases

#3113
20170326118
2017-11-16

Drug treatment of tumors wherein hedgehog/smoothened signaling is utilized for inhibition of apoptosis of tumor cells

#3114
20170326112
2017-11-16

Device for delivery of a pharmaceutical composition

#3115
20170326087
2017-11-16

Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate

#3116
20170321043
2017-11-09

COMPOSITION OF SOLUBLE INDIGESTABLE FIBERS AND OF EUKARYOTIC ORGANISMS WITH A POLYSACCHARIDE WALL, USED, IN THE WELL-BEING FIELD

#3117
20170320961
2017-11-09

Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia

#3118
20170320949
2017-11-09

Therapeutic agent for autoimmune diseases comprising PD-1 agonist

#3119
20170320825
2017-11-09

Pentadienoyl piperidine derivative and use thereof

#3120
20170320823
2017-11-09

Synergistic compositions

#3121
20170320818
2017-11-09

SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION

#3122
20170319757
2017-11-09

Catheter locking solution having antimicrobial and anticoagulation properties

#3123
20170319707
2017-11-09

Combination of drugs with protein-binding prodrugs

#3124
20170319694
2017-11-09

DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS

#3125
20170319691
2017-11-09

Combination therapy for treating breast cancer

#3126
20170319689
2017-11-09

Methods, regimens, combinations and antagonists

#3127
20170319668
2017-11-09

AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE

#3128
20170319617
2017-11-09

COMPOSITION FOR THE TREATMENT OF DISEASE

#3129
20170319611
2017-11-09

METHODS AND COMPOSITIONS COMPRISING AKT INHIBITORS AND/OR PHOSPHOLIPASE D INHIBITORS

#3130
20170319589
2017-11-09

Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates

#3131
20170319578
2017-11-09

Compounds and their use as BACE inhibitors

#3132
20170319572
2017-11-09

COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION

#3133
20170319569
2017-11-09

COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE

#3134
20170319550
2017-11-09

CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF UVEITIS

#3135
20170319547
2017-11-09

Anesthetic comprising tetracaine and a vasoconstrictor for administration to a subject

#3136
20170319533
2017-11-09

Compositions and methods of use of phorbol esters

#3137
20170319508
2017-11-09

Curcuphenol compounds for increasing MHC-I expression

#3138
20170319479
2017-11-09

ENHANCED STABILITY OF NOVEL LIQUID COMPOSITIONS

#3139
20170318806
2017-11-09

Lice control composition and method

#3140
20170314006
2017-11-02

Beta-lactamases with improved properties for therapy

#3141
20170312284
2017-11-02

Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7

#3142
20170312219
2017-11-02

METHOD OF CONTRACEPTION

#3143
20170306421
2017-10-26

GENE DRO1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME

#3144
20170306322
2017-10-26

METHODS AND MATERIALS FOR IDENTIFYING COMPOUNDS PROMOTING TRANSLATIONAL READ-THROUGH OF NONSENSE MUTATIONS

#3145
20170304387
2017-10-26

Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutical composition

#3146
20170304383
2017-10-26

Small molecule Ras inhibitors

#3147
20170304361
2017-10-26

HALOGENATED INSULIN ANALOGUES OF ENHANCED BIOLOGICAL POTENCY

#3148
20170304358
2017-10-26

PRIMARY AND SECONDARY PREVENTION OF DEMENTIAS AND SUICIDE WITH TRACE DOSE LITHIUM

#3149
20170304350
2017-10-26

PHARMACEUTICAL COMPOSITION FOR TREATING A VIRAL INFECTION

#3150
20170304316
2017-10-26

Ophthalmic solution

#3151
20170304298
2017-10-26

Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

#3152
20170304277
2017-10-26

Tetrahydropyrazolopyridine derivatives as ghrelin receptor agonists

#3153
20170304273
2017-10-26

Dyslipidemia therapeutic agent

#3154
20170304228
2017-10-26

NEW INDICATION OF CINACALCET HCL PHARMACEUTICAL COMPOSITION FOR TREATING CANCER

#3155
20170304217
2017-10-26

Use of cannabinoids in the treatment of degenerative skeletal muscle diseases

#3156
20170304216
2017-10-26

Estrogen receptor ligand treatment for neurodegenerative diseases

#3157
20170304204
2017-10-26

Compositions and methods for increasing the bioavailability of one or more compounds

#3158
20170296612
2017-10-19

Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders

#3159
20170296501
2017-10-19

Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans

#3160
20170291882
2017-10-12

Solid Forms of Mirabegron

#3161
20170290829
2017-10-12

Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

#3162
20170290809
2017-10-12

Antiviral agents and uses thereof

#3163
20170290806
2017-10-12

PCSK9 Inhibitors and Methods of Use Thereof

#3164
20170283386
2017-10-05

Aminoalkylbenzothiazepine derivatives and uses thereof

#3165
20170281810
2017-10-05

Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases

#3166
20170281779
2017-10-05

METHOD OF TREATING PATIENTS NON-RESPONSIVE TO PALONOSETRON

#3167
20170281771
2017-10-05

METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS

#3168
20170281757
2017-10-05

PROBIOTICS, SECRETORY IgA AND INFECTION

#3169
20170281733
2017-10-05

Combination of an insulin and a GLP-1 agonist

#3170
20170281731
2017-10-05

UNITARY COMBINATION OF FSH AND HCG

#3171
20170281722
2017-10-05

Treatment of Constipation-Predominant Irritable Bowel Syndrome

#3172
20170281713
2017-10-05

A METHOD FOR SIDE EFFECT REDUCTION IN THE USE OF STATINS VIA PHYSIOLOGICALLY SYNTHESIZED GLUTATHIONE

#3173
20170281699
2017-10-05

Method of identifying a biologically-active composition from a biofilm

#3174
20170281680
2017-10-05

Scaffold Delivery of Immune Suppressors and Transplant Material for Control of Transplant Rejection

#3175
20170281673
2017-10-05

USE OF NITRITE SALTS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS

#3176
20170281672
2017-10-05

Systems and methods for delivery of peptides

#3177
20170281671
2017-10-05

NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS

#3178
20170281661
2017-10-05

Use of sedoheptulose for prevention or treatment of inflammation

#3179
20170281659
2017-10-05

Use of thiopyrimidinecarboxamide for treating cancer

#3180
20170281658
2017-10-05

Methods of treating retroviral infections and related dosage regimes

#3181
20170281652
2017-10-05

Therapeutic Compositions and Methods

#3182
20170281638
2017-10-05

Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof

#3183
20170281636
2017-10-05

ANTIVIRAL THERAPY

#3184
20170281620
2017-10-05

CHEMICALLY AND METABOLICALLY STABLE DIPEPTIDE POSSESSING POTENT SODIUM CHANNEL BLOCKER ACTIVITY

#3185
20170281619
2017-10-05

Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor

#3186
20170281617
2017-10-05

Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

#3187
20170281613
2017-10-05

Combination therapy

#3188
20170281608
2017-10-05

Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions

#3189
20170281606
2017-10-05

Methods of treating hepatic encephalopathy

#3190
20170281604
2017-10-05

Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders

#3191
20170281577
2017-10-05

Treatment of cancer with specific RXR agonists

#3192
20170281576
2017-10-05

Treatment of cancer with specific RXR agonists

#3193
20170281571
2017-10-05

METHODS FOR THE TREATMENT OF ROSACEA

#3194
20170281564
2017-10-05

THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID COMPOSITION AND ASSOCIATED METHOD

#3195
20170281563
2017-10-05

Method of reducing scarring

#3196
20170281546
2017-10-05

Taurine compositions suitable for inhalation

#3197
20170280730
2017-10-05

Compositions and methods useful for the prevention of malaria and dengue virus transmission

#3198
20170275673
2017-09-28

Methods and compositions related to prostate cancer therapeutics

#3199
20170275617
2017-09-28

Compositions and methods for treating or preventing lupus

#3200
20170275591
2017-09-28

Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1

#3201
20170275584
2017-09-28

Method of making an artificial micro-gland using taxis

#3202
20170275375
2017-09-28

Combination therapy with T-cell redirecting bispecific antibodies and checkpoint inhibitors

#3203
20170275367
2017-09-28

Bispecific EGFR/C-Met Antibodies

#3204
20170275288
2017-09-28

PTERIDINES USEFUL AS HCV INHIBITORS AND METHODS FOR THE PREPARATION THEREOF

#3205
20170275273
2017-09-28

Estrogen receptor modulators and uses thereof

#3206
20170274104
2017-09-28

Methods, compositions and kits for providing a therapeutic treatment

#3207
20170274093
2017-09-28

COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER

#3208
20170274080
2017-09-28

Method for reducing damage caused by free radicals

#3209
20170274052
2017-09-28

METHOD AND APPARATUS FOR HARVESTING, CREATING AND IMPLANTING A FIBRIN CLOT BIOMATERIAL

#3210
20170274051
2017-09-28

Pharmaceutical compositions and methods

#3211
20170274033
2017-09-28

Methods and materials for increasing lean muscle mass

#3212
20170274032
2017-09-28

PHARMACEUTICAL COMPOSITIONS FOR TREATING ANXIETY

#3213
20170274030
2017-09-28

Buccal and sublingual cannabinoid formulations and method of making the same

#3214
20170274021
2017-09-28

Method for preparing a biological tissue construct and use of autologous cells obtained specifically

#3215
20170274015
2017-09-28

PLATELET RICH PLASMA FORMULATIONS AND USE THEREOF

#3216
20170274010
2017-09-28

Immune modulation using peptides and other compositions

#3217
20170274002
2017-09-28

MULTIPLE FOLATE FORMULATION AND USE THEREOF

#3218
20170273992
2017-09-28

Pharmaceutical compositions for preventing glucocorticoid-induced corneal thinning

#3219
20170273991
2017-09-28

Treatment of congestion using steroids and adrenergics

#3220
20170273989
2017-09-28

Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction

#3221
20170273972
2017-09-28

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

#3222
20170273954
2017-09-28

METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS

#3223
20170273952
2017-09-28

Methods of treating liver disease

#3224
20170273945
2017-09-28

Pharmaceutical composition for topical administration

#3225
20170273942
2017-09-28

Taxane Analogs for the Treatment of Brain Cancer

#3226
20170273934
2017-09-28

Treatment of Triple Receptor Negative Breast Cancer

#3227
20170273933
2017-09-28

Anti-tumor compound and the medical use thereof

#3228
20170273930
2017-09-28

Methods to treat neurodegenerative diseases

#3229
20170273928
2017-09-28

Composition for preventing the occurrence of cardiovascular event in multiple risk patient

#3230
20170273919
2017-09-28

Therapeutic approaches for treating Parkinson's disease

#3231
20170273915
2017-09-28

Specific mTOR inhibitors in the treatment of X-linked adrenoleukodystrophy

#3232
20170273896
2017-09-28

Controlled extended release pregabalin

#3233
20170268009
2017-09-21

Methods and pharmaceutical compositions for treatment of cystic fibrosis

#3234
20170268004
2017-09-21

MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION

#3235
20170266262
2017-09-21

Fibrinogen preparations enriched in fibrinogen with an extended alpha chain

#3236
20170266251
2017-09-21

HERBAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND RELATED DISORDERS

#3237
20170266245
2017-09-21

Hydrogenation of cannabis oil

#3238
20170266239
2017-09-21

Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them

#3239
20170266231
2017-09-21

Processing methods of solgel-derived bioactive glass-ceramic compositions and methods of using the same

#3240
20170266227
2017-09-21

Acetic acid and hypochlorous acid compositions for treatment of biofilms and wound care

#3241
20170266226
2017-09-21

Anti-inflammatory solution

#3242
20170266212
2017-09-21

Prevention or treatment agent for hepatic fibrosis

#3243
20170266207
2017-09-21

COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING

#3244
20170266190
2017-09-21

Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist

#3245
20170266186
2017-09-21

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#3246
20170266170
2017-09-21

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

#3247
20170266150
2017-09-21

USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTFORME AND MEDULLOBLASTOMA

#3248
20170266148
2017-09-21

Compositions and methods for producing elevated and sustained ketosis

#3249
20170266139
2017-09-21

INJECTABLE RESINIFERATOXIN

#3250
20170266129
2017-09-21

Foods, systems, methods, and kits for providing electrolyte replacement

#3251
20170266126
2017-09-21

Use of cannabinoids in the treatment of epilepsy

#3252
20170258919
2017-09-14

Colon cleansing compositions and methods of use

#3253
20170258911
2017-09-14

Stable pharmaceutical formulations of methylnaltrexone

#3254
20170258909
2017-09-14

USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION

#3255
20170258900
2017-09-14

Immunostimulating Polyphosphazene Compounds

#3256
20170258883
2017-09-14

Protease-engineered Cancer Cell Spheres as an Immunotherapy to Treat Cancer and non-Cancer Diseases

#3257
20170258861
2017-09-14

Treatment of Herpes, Pseudomonas, Staph, and Hepatitis

#3258
20170258856
2017-09-14

and subsp. for use in prevention or treatment of upper respiratory tract infections

#3259
20170258839
2017-09-14

Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

#3260
20170258825
2017-09-14

AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS

#3261
20170258796
2017-09-14

Methods and compositions to reduce oxidative stress

#3262
20170258788
2017-09-14

CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATMENT OF MOOD DISORDERS

#3263
20170258780
2017-09-14

TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD

#3264
20170258757
2017-09-14

ANTI-CANCER AGENT DELIVERY VEHICLES CAPABLE OF IMPROVED LOADING

#3265
20170258752
2017-09-14

Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states

#3266
20170258746
2017-09-14

ACETIC ACID/THYMOL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ONYCHOMYCOSIS

#3267
20170258745
2017-09-14

Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis

#3268
20170258744
2017-09-14

Treatment of prostate carcinoma

#3269
20170258740
2017-09-14

Treatment and prevention of cardiovascular disease and thrombosis

#3270
20170258707
2017-09-14

Topical skin care formulations comprising botanical extracts

#3271
20170252443
2017-09-07

Methods for reversing multiple resistance in animal cells

#3272
20170252407
2017-09-07

Peptides and compositions for treatment of joint damage

#3273
20170252403
2017-09-07

METHODS AND COMPOSITIONS FOR TREATING RETINAL DISORDERS

#3274
20170252398
2017-09-07

Brain and neural treatments comprising peptides and other compositions

#3275
20170252374
2017-09-07

MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO

#3276
20170252361
2017-09-07

Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome

#3277
20170252336
2017-09-07

USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION

#3278
20170252327
2017-09-07

Methods of Modulating Gastrointestinal Tract Flora Levels with Alkaline Phosphatase

#3279
20170252325
2017-09-07

MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY

#3280
20170252320
2017-09-07

Wound healing

#3281
20170252314
2017-09-07

Method of treating neuropathic pain with a synergistic pharmaceutical composition comprising palmitoylethanolamide and L-acetylcarnitine

#3282
20170252313
2017-09-07

Omega-3 compositions, dosage forms, and methods of use

#3283
20170252308
2017-09-07

REDUCING MYOCARDIAL DAMAGE AND THE INCIDENCE OF ARRHYTHMIA ARISING FROM LOSS, REDUCTION OR INTERRUPTION IN CORONARY BLOOD FLOW

#3284
20170251660
2017-09-07

Methods for treating red blood cells

#3285
20170247344
2017-08-31

Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases

#3286
20170246339
2017-08-31

Hemostatic compositions and dressings for bleeding

#3287
20170246299
2017-08-31

Compositions and methods for treatment of pre-cancerous skin lesions

#3288
20170246288
2017-08-31

MULTILAMELLAR LIPID VESICLE COMPOSITIONS AND METHODS OF USE

#3289
20170246221
2017-08-31

Altering microbial populations and modifying microbiota

#3290
20170246176
2017-08-31

PHACOSCLEROSIS INHIBITOR

#3291
20170246169
2017-08-31

Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors

#3292
20170246147
2017-08-31

COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER

#3293
20170246146
2017-08-31

POLYPHENOL FOR WOUND HEALING

#3294
20170246145
2017-08-31

Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections

#3295
20170246143
2017-08-31

Compositions and methods for preventing and recovery from detrimental effects of alcohol consumption

#3296
20170246134
2017-08-31

Famciclovir and celecoxib combination therapy for functional somatic syndromes

#3297
20170246125
2017-08-31

Method of treating or preventing tumors of the central nervous system

#3298
20170240862
2017-08-24

Acellular biologic composition and method of manufacture

#3299
20170240843
2017-08-24

Omega-3 fatty acid ester compositions

#3300
20170239390
2017-08-24

Biologic composition and method of manufacture